Natriuretic Peptide, Brain
"Natriuretic Peptide, Brain" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
Descriptor ID |
D020097
|
MeSH Number(s) |
D06.472.699.584.625 D12.644.548.585.625 D12.776.631.590
|
Concept/Terms |
Natriuretic Peptide, Brain- Natriuretic Peptide, Brain
- Peptide, Brain Natriuretic
- BNP-32
- BNP 32
- Brain Natriuretic Peptide-32
- Brain Natriuretic Peptide 32
- Natriuretic Peptide-32, Brain
- Peptide-32, Brain Natriuretic
- Natriuretic Factor-32
- Natriuretic Factor 32
- BNP Gene Product
- Type-B Natriuretic Peptide
- Natriuretic Peptide, Type-B
- Type B Natriuretic Peptide
- Natriuretic Peptide Type-B
- Natriuretic Peptide Type B
- Nesiritide
- Brain Natriuretic Peptide
- B-Type Natriuretic Peptide
- Natriuretic Peptide, B-Type
|
Below are MeSH descriptors whose meaning is more general than "Natriuretic Peptide, Brain".
Below are MeSH descriptors whose meaning is more specific than "Natriuretic Peptide, Brain".
This graph shows the total number of publications written about "Natriuretic Peptide, Brain" by people in this website by year, and whether "Natriuretic Peptide, Brain" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 | 2003 | 2 | 0 | 2 | 2005 | 2 | 0 | 2 | 2006 | 3 | 2 | 5 | 2007 | 0 | 1 | 1 | 2008 | 3 | 1 | 4 | 2009 | 5 | 3 | 8 | 2010 | 2 | 4 | 6 | 2011 | 3 | 8 | 11 | 2012 | 1 | 3 | 4 | 2013 | 1 | 1 | 2 | 2014 | 3 | 3 | 6 | 2015 | 0 | 4 | 4 | 2016 | 0 | 2 | 2 | 2017 | 1 | 2 | 3 | 2018 | 4 | 1 | 5 | 2019 | 0 | 1 | 1 | 2020 | 1 | 1 | 2 | 2021 | 3 | 3 | 6 | 2022 | 0 | 3 | 3 | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Natriuretic Peptide, Brain" by people in Profiles.
-
Marston NA, Garfinkel AC, Kamanu FK, Melloni GM, Roselli C, Jarolim P, Berg DD, Bhatt DL, Bonaca MP, Cannon CP, Giugliano RP, O'Donoghue ML, Raz I, Scirica BM, Braunwald E, Morrow DA, Ellinor PT, Lubitz SA, Sabatine MS, Ruff CT. A polygenic risk score predicts atrial fibrillation in cardiovascular disease. Eur Heart J. 2023 01 14; 44(3):221-231.
-
Judge DP, Lakdawala NK, Taylor MRG, Mestroni L, Li H, Oliver C, Angeli FS, Lee PA, MacRae CA. Long-Term Efficacy and Safety of ARRY-371797 (PF-07265803) in Patients With Lamin A/C-Related Dilated Cardiomyopathy. Am J Cardiol. 2022 11 15; 183:93-98.
-
Park E, Ito K, Iqbal R, Amigues I, Bokhari S, Van Eyk J, Depender C, Giles JT, Bathon J. Prospective changes in diastolic function in patients with rheumatoid arthritis. Arthritis Res Ther. 2022 08 05; 24(1):184.
-
Parcha V, Irvin MR, Lange LA, Armstrong ND, Pampana A, Meyer M, Judd SE, Arora G, Arora P. Corin Missense Variants, Blood Pressure, and Hypertension in 11?322 Black Individuals: Insights From REGARDS and the Jackson Heart Study. J Am Heart Assoc. 2022 06 21; 11(12):e025582.
-
Hernandez AF, Albert NM, Allen LA, Ahmed R, Averina V, Boehmer JP, Cowie MR, Chien CV, Galvao M, Klein L, Kwan B, Lam CSP, Ruble SB, Stolen CM, Stein K. Multiple cArdiac seNsors for mAnaGEment of Heart Failure (MANAGE-HF) - Phase I Evaluation of the Integration and Safety of the HeartLogic Multisensor Algorithm in Patients With Heart Failure. J Card Fail. 2022 08; 28(8):1245-1254.
-
Miyoshi T, Hosoda H, Miyake A, Sakaguchi H, Kitano M, Kurosaki KI, Shiraishi I, Nakai M, Nishimura K, Miyazato M, Kangawa K, Yoshimatsu J, Minamino N. Utility of perinatal natriuretic peptide for predicting neonatal heart failure. Pediatr Int. 2022 Jan; 64(1):e15231.
-
Griffiths M, Yang J, Vaidya D, Nies M, Brandal S, Ivy DD, Hickey F, Wolter-Warmerdam K, Austin ED, Mullen M, Pauciulo MW, Lutz KA, Rosenzweig EB, Hirsch R, Yung D, Nichols WC, Everett AD. Biomarkers of Pulmonary Hypertension Are Altered in Children with Down Syndrome and Pulmonary Hypertension. J Pediatr. 2022 02; 241:68-76.e3.
-
Berg DD, Freedman BL, Bonaca MP, Jarolim P, Scirica BM, Goodrich EL, Sabatine MS, Morrow DA. Cardiovascular Biomarkers and Heart Failure Risk in Stable Patients With Atherothrombotic Disease: A Nested Biomarker Study From TRA 2?P-TIMI 50. J Am Heart Assoc. 2021 05 04; 10(9):e018673.
-
Wijkman MO, Claggett BL, Pfeffer MA, Par? G, McQueen M, Hess S, Lee SF, Gerstein HC. NT-proBNP versus routine clinical risk factors as a predictor of cardiovascular events or death in people with dysglycemia - A brief report from the ORIGIN trial. J Diabetes Complications. 2021 07; 35(7):107928.
-
Humbert M, McLaughlin V, Gibbs JSR, Gomberg-Maitland M, Hoeper MM, Preston IR, Souza R, Waxman A, Escribano Subias P, Feldman J, Meyer G, Montani D, Olsson KM, Manimaran S, Barnes J, Linde PG, de Oliveira Pena J, Badesch DB. Sotatercept for the Treatment of Pulmonary Arterial Hypertension. N Engl J Med. 2021 04 01; 384(13):1204-1215.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|